Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Korea.
Sci Rep. 2020 Nov 12;10(1):19648. doi: 10.1038/s41598-020-76748-1.
We sought to identify biomarkers in the amniotic fluid (AF) and specific signaling pathways related to spontaneous preterm delivery (SPTD, < 34 weeks) in women with preterm labor (PTL) without intra-uterine infection/inflammation (IUI). This was a retrospective cohort study of a total of 139 PTL women with singleton gestation (24 + 0 to 32 + 6 weeks) who underwent amniocentesis and who displayed no evidence of IUI. A nested case-control was conducted using pooled AF samples (n = 20) analyzed via label-free liquid chromatography-tandem mass spectrometry. In the total cohort, an ELISA validation study was performed for seven candidate proteins of interest. Proteomic analysis identified 77 differentially expressed proteins (DEPs, P < 0.05) in the AF from SPTD cases compared to term delivery controls. ELISA validation confirmed that women who had an SPTD before 34 weeks had significantly independently lower levels of VEGFR-1 and higher levels of lipocalin-2 and the Fc fragment of IgG binding protein in the AF. Five principle pathways associated with the 77 DEPs were identified, including glycolysis, gluconeogenesis, and iron homeostasis. The proteomic analysis data of AFs from women with PTL identified several novel biomarkers and specific protein pathways related to SPTD in the absence of IUI.
我们旨在鉴定早产(PTL,<34 周)孕妇羊水中与自发性早产(SPTD,<34 周)相关的生物标志物和特定信号通路,这些孕妇的 PTL 不伴有宫内感染/炎症(IUI)。这是一项回顾性队列研究,共纳入了 139 名单胎妊娠(24+0 至 32+6 周)PTL 孕妇,这些孕妇均进行了羊膜穿刺术,且无 IUI 证据。使用无标记液相色谱-串联质谱法分析了 20 例合并的羊水样本,进行了巢式病例对照研究。在总队列中,对 7 种候选感兴趣蛋白进行了 ELISA 验证研究。蛋白质组学分析鉴定了 SPTD 病例与足月分娩对照组相比,羊水中有 77 种差异表达蛋白(DEPs,P<0.05)。ELISA 验证证实,在 34 周前发生 SPTD 的孕妇,其羊水 VEGFR-1 水平明显独立降低,脂联素-2 和 IgG 结合蛋白 Fc 片段水平明显独立升高。确定了与 77 个 DEPs 相关的 5 个主要途径,包括糖酵解、糖异生和铁稳态。PTL 孕妇羊水的蛋白质组学分析数据确定了几个与 IUI 无关的 SPTD 相关的新型生物标志物和特定蛋白途径。